Leflunomide in dermatology

Journal of the American Academy of Dermatology

Volumn 66, Issue 4, 2012, Pages 673-679

  Boyd, Alan S ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

atopic dermatitis; dihydroorotate dehydrogenase; leflunomide; psoriasis; psoriatic arthritis; rheumatoid arthritis; tumor necrosis factor alfa

Indexed keywords

ACTIVATED CARBON; ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CIPROFLOXACIN; COLESTYRAMINE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; RIFAMPICIN; TERIFLUNOMIDE; TUMOR NECROSIS FACTOR ALPHA; WARFARIN;

ABDOMINAL PAIN; ALOPECIA; ALOPECIA AREATA; ANKYLOSING SPONDYLITIS; AORTA ARCH SYNDROME; ATOPIC DERMATITIS; BULLOUS PEMPHIGOID; DERMATOLOGY; DIARRHEA; DOWN REGULATION; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG POTENTIATION; DRUG WITHDRAWAL; DYSPEPSIA; ENZYME INHIBITION; ERYTHEMA MULTIFORME; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERSENSITIVITY REACTION; HYPERTENSION; LEG ULCER; LEUKOCYTOCLASTIC VASCULITIS; LICHEN PLANUS; LIVER TOXICITY; LUPUS ERYTHEMATOSUS; MOUTH ULCER; NAUSEA; PRIORITY JOURNAL; PSORIASIS; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; QUALITY OF LIFE; REITER SYNDROME; RETICULOHISTIOCYTOSIS; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SAPHO SYNDROME; SARCOIDOSIS; SCLEROSIS; SIDE EFFECT; SJOEGREN SYNDROME; SKIN INFECTION; SYRINGOTROPIC HYPERSENTSITIVITY REACTION; SYSTEMIC LUPUS ERYTHEMATOSUS; TOXIC EPIDERMAL NECROLYSIS; TRANSCRIPTION REGULATION; TREATMENT RESPONSE; ULCER; WEIGHT REDUCTION;

HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISOXAZOLES; PSORIASIS; SKIN DISEASES;

EID: 84858336657     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2011.08.025     Document Type: Review

References (65)

1. N.J. Olsen, and C.M. Stein New drugs for rheumatoid arthritis N Engl J Med 350 2004 2167 2177
2. F.C. Breedveld, and J.M. Dayer Leflunomide: mode of action in the treatment of rheumatoid arthritis Ann Rheum Dis 59 2000 841 849
3. G.C. Liang, and W.G. Barr Open trial of leflunomide for refractory psoriasis and psoriatic arthritis J Clin Rheumatol 7 2001 366 370
4. J.P. Kaltwasser, P. Nash, D. Gladman, C.F. Rosen, F. Behrens, and P. Jones Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial Arthritis Rheum 50 2004 1939 1950
5. P. Nash, D. Thaci, F. Behrens, F. Falk, and J.P. Kaltwasser Leflunomide improves psoriasis in patients with psoriatic arthritis: an in-depth analysis of data from the TOPAS study Dermatology 212 2006 238 249
6. V. Ravindran, D.L. Scott, and E.H. Choy A systematic review and meta-analysis of efficacy and toxicity of disease modifying anti-rheumatic drugs and biological agents for psoriatic arthritis Ann Rheum Dis 67 2008 855 859
7. U. Frieling, and T.A. Luger Mycophenolate mofetil and leflunomide: promising compounds for the treatment of skin diseases Clin Exp Dermatol 27 2002 562 570
8. G.P. Thami, and G. Garg Leflunomide in psoriasis and psoriatic arthritis: a preliminary study Arch Dermatol 140 2004 1288 1289
9. V. Majithia, S. Sanders, V. Harisdangkul, and J.G. Wilson Successful treatment of sarcoidosis with leflunomide Rheumatology 42 2003 700 702
10. J.S. Boswell, and M.I. Costner Leflunomide as adjuvant treatment of dermatomyositis J Am Acad Dermatol 58 2008 403 406
11. J.M. Kremer Methotrexate and leflunomide: biochemical basis for combination therapy in the treatment of rheumatoid arthritis Semin Arthritis Rheum 29 1999 14 26
12. X. Xu, J.W. Williams, H. Gong, A. Finnegan, and A.S.F. Chong Two activities of the immunosuppressive metabolite of leflunomide, A77 1726: inhibition of pyrimidine nucleotide synthesis and protein tyrosine phosphorylation Biochem Pharmacol 52 1996 527 534
13. K. Reich, K.M. Hummel, I. Beckmann, R. Mossner, and C. Neumann Treatment of severe psoriasis and psoriatic arthritis with leflunomide Br J Dermatol 146 2002 335 336
14. A.A. Lonsdale-Eccles, A.E. Haworth, F.C. McCrab, and S.A. Young-Min Successful treatment of multicentric reticulohistiocytosis with leflunomide Br J Dermatol 161 2009 470 472
15. A. Mirmohammadsadcgh, B. Nomey, H.F. Abts, K. Kohrer, T. Rizicka, and G. Michel Differential modulation of pro- and anti-inflammatory cytokine receptors by N-(trifluoromethylphenyl)-2-cyano-3-hydroxy-crotonic acid amide (A77 1726), the physiologically active metabolite of the novel immunomodulator leflunomide Biochem Pharmacol 55 1998 1523 1529
16. J.A. Tacuilo-Parra, E. Guevara-Gutierrez, M.A. Rodriguez-Castellanos, J.M. Ornelas-Aguirre, J.F. Barba-Gomez, and M. Salazar-Paramo Leflunomide in the treatment of psoriasis: results of a phase II open trial Br J Dermatol 150 2004 970 976
17. J. Schmitt, G. Wozel, and C. Pfeiffer Leflunomide as a novel treatment option in severe atopic dermatitis Br J Dermatol 150 2004 1182 1185
18. S. Cohen, G.W. Cannon, M. Schiff, A. Weaver, R. Fox, and N. Olsen Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate Arthritis Rheum 44 2001 1984 1992
19. M. Osiri, B. Shea, V. Robinson, M. Suarez-Almazor, V. Strand, and P. Tugwell Leflunomide for the treatment of rheumatoid arthritis: a systematic review and meta-analysis J Rheumatol 30 2003 1182 1190
20. J.S. Coblyn, N. Shadick, and A. Helfgott Leflunomide-associated weight loss in rheumatoid arthritis Arthritis Rheum 44 2001 1048 1052
21. E.N. van Roon, T.L. Jansen, N.M. Houtman, P. Spoelstra, and J.R. Brouwers Leflunomide for the treatment of rheumatoid arthritis in clinical practice: incidence and severity of hepatotoxicity Drug Saf 27 2004 345 352
22. J. Auer, M. Hinterreiter, S. Allinger, A. Kirschgatterer, and P. Knoflach Severe pancytopenia after leflunomide in rheumatoid arthritis Acta Med Austriaca 27 2000 131 132
23. C. Metzler, A.C. Arlt, W.L. Gross, and J. Brandt Peripheral neuropathy in patients with systemic rheumatic diseases treated with leflunomide Ann Rheum Dis 64 2005 1798 1800
24. S. Suissa, M. Hudson, and P. Ernst Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis Arthritis Rheum 54 2006 1435 1439
25. T. Sawada, S. Inokuma, T. Satao, T. Otsuka, Y. Sacki, and T. Takeuchi Leflunomide-induced interstitial lung disease: prevalence and risk factors in Japanese patients with rheumatoid arthritis Rheumatology 48 2009 1069 1072
26. S. Inokuma, T. Sato, A. Sagawa, T. Matsuda, T. Takemura, and T. Ohtsuka Proposals for leflunomide use to avoid lung injury inpatients with rheumatoid arthritis Mod Rheumatol 18 2008 442 446
27. N. Alcorn, S. Saunders, and R. Madhok Benefit-risk assessment of leflunomide: an appraisal of leflunomide in rheumatoid arthritis 10 years after licensing Drug Saf 32 2009 1123 1134
28. J.S. Smolen, J.R. Kalden, D.L. Scott, B. Rozman, T.K. Kvien, and A. Larsen Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomized, multicenter trial Lancet 353 1999 259 266
29. V. Lim, and I. Pande Leflunomide can potentiate the anticoagulant effect of warfarin BMJ 325 2002 1333
30. A. Prakash, and B. Jarvis Leflunomide: a review of its use in active rheumatoid arthritis Drugs 58 1999 1137 1164
31. O.A. Kerr, C.S. Murray, and M.J. Tidman Subacute cutaneous lupus erythematosus associated with leflunomide Clin Exp Dermatol 29 2004 319 320
32. S.K. Chan, B.L. Hazleman, and N.P. Burrows Subacute cutaneous lupus erythematosus precipitated by leflunomide Clin Exp Dermatol 30 2005 724 725
33. V. Goeb, J.M. Berthelot, P. Joly, O. Mejjad, J. de Quatrebarbes, and C. Reynaud-Hautin Leflunomide-induced subacute cutaneous lupus erythematosus Rheumatology 44 2005 823 824
34. D. Gensburger, M. Kawashima, H. Marotte, J. Kanitakis, and P. Miossec Lupus erythematosus with leflunomide: induction or reactivation? Ann Rheum Dis 64 2005 153 155
35. A.V. Marzano, S. Ramoni, N. Del Papa, M. Barbareschi, and E. Alessi Leflunomide-induced subacute cutaneous lupus erythematosus with erythema multiforme-like lesions Lupus 17 2008 329 331
36. T.W. Fischer, J.I. Bauer, T. Graafe, U. Barta, and P. Elsner Erythema multiforme-like drug eruption with oral involvement after intake of leflunomide Dermatology 207 2003 386 389
37. Y. Teraki, K. Hitomi, Y. Sata, Y. Hamamatsu, and S. Izaki Leflunomide-induced toxic epidermal necrolysis Int J Dermatol 45 2006 1370 1371
38. H. Hassikou, M. El Haouri, F. Tabache, M. Baaj, S. Sasfi, and L. Hadri Leflunomide-induced toxic epidermal necrolysis in a patient with rheumatoid arthritis Joint Bone Spine 75 2008 597 599
39. X. Jian, G. Guo, Y. Ruan, D. Lin, and X. Li Severe cutaneous adverse drug reaction to leflunomide: a report of two cases Cutan Ocul Toxicol 27 2008 5 9
40. L. Statescu, D. Ciobanu, G. Mihaila, C. Statescu, and L.G. Solovastru Lichen planus-like eruption: case report Rev Med Chir Soc Med Nat Iasi 113 2009 1102 1106
41. E. Rivarola de Gutierrez, and H. Abaca Photodistributed lichenoid drug eruption with rhabdomyolysis occurring during leflunomide therapy Dermatology 208 2004 232 233
42. A.M. Thielen, C. Barde, V. Janer, L. Boradori, and J.H. Saurat Reiter syndrome triggered by adalimumab (Humira®) and leflunomide (Arava®) in a patient with ankylosing spondylarthropathy and Crohn's disease Br J Dermatol 156 2007 188 189
43. E.A. Holm, E. Balslev, and G.B.E. Jemec Vasculitis occurring during leflunomide therapy Dermatology 203 2001 258 259
44. A.T.Y. Chan, A. Bradlow, and B.J. McNally Leflunomide-induced vasculitis-a dose response relationship Rheumatology 42 2003 492 493
45. C.M. McCoy Leflunomide-associated skin ulceration Ann Pharmacother 36 2002 1009 1011
46. J.E. Gottenberg, P.Y. Venancie, and X. Mariette Alopecia areata in a patient with rheumatoid arthritis treated with leflunomide J Rheumatol 29 2002 1806 1807
47. T. Vewel, B. Luzar, E. Calonje, and T. Avcin Syringotropic hypersensitivity reaction associated with infliximab and leflunomide combination therapy in a child with psoriatic arthritis J Cutan Pathol 36 2009 991 994
48. C. Gros, F. Delesalle, S. Gautier, and E. Delaporte Leflunomide-induced skin necrosis Ann Dermatol Venereol 135 2008 205 208
49. S. Di Nuzzo, M. Zanni, and G. De Panfilis Cutaneous ulceration induced by leflunomide in a psoriatic patient Int J Dermatol 48 2009 666 668
50. J.G.E. Smeet, S.H. Lowe, and J.C.J.M. Veraart Cutaneous infections with Stenotrophomonas maltophilia in patients using immunosuppressive medication J Eur Acad Dermatol Venereol 21 2007 1298 1300
51. F. Manguso, A. Oriente, R. Peluso, and P. Oriente Leflunomide in psoriatic polyarthritis: an Italian pilot study Arthritis Rheum 44 Suppl 2001 S92
52. J.R. Curtis, T. Beukelman, A. Onofrei, S. Cassell, J.D. Greenberg, and A. Kavanaugh Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide Ann Rheum Dis 69 2010 43 47
53. S. Scarpato, and E. Tirri Successful treatment of SAPHO syndrome with leflunomide: report of two cases Clin Exp Rheumatol 23 2005 731
54. P.M. Melwani, Y. Penate, N. Guillermo, E. Soler, B. Hernandez-Machin, and L. Borrego Leflunomide in the treatment of palmoplantar pustulosis Arch Dermatol 145 2009 1224 1226
55. C.F. Remer, M.H. Weisman, and D.J. Wallace Benefits of leflunomide in systemic lupus erythematosus: a pilot observational study Lupus 10 2001 480 483
56. L.S. Tam, E.K. Li, C.K. Wong, C.W.K. Lam, and C.C. Szeto Double-blind, randomized, placebo-controlled pilot study of leflunomide in systemic lupus erythematosus Lupus 13 2004 601 604
57. A. Suess, and M. Sticherling Leflunomide in subacute cutaneous lupus erythematosus-two sides of a coin Int J Dermatol 47 2008 83 86
58. J.M. van Woerkom, A.A. Kruize, R. Geenen, E.N. van Roon, R. Goldschmeding, and S.M.M. Verstappen Safety and efficacy of leflunomide in primary Sjögren's syndrome: a phase II pilot study Ann Rheum Dis 66 2007 1026 1032
59. M. Sebastiani, D. Giuggioli, E. Vesprini, A. Caruso, and C. Ferri Successful treatment with leflunomide of arthritis in systemic sclerosis patients Rheumatology 45 2006 1175 1176
60. V.S. Sangle, S.R. Sangle, and D.P. D'Cruz Leflunomide as a remission-maintaining therapy in difficult-to-treat dermatomyositis Ann Rheum Dis 67 2008 723
61. G. Wozel, L. Vitez, and C. Pfeiffer Severe atopic dermatitis and leflunomide: first clinical experience and highlights of pertinent experimental data Dermatol Online J 12 2008 6
62. H.C. Nousari, and G.J. Anhalt Bullous pemphigoid treated with leflunomide: a novel immunomodulatory agent Arch Dermatol 136 2000 1204 1205
63. R.P. Baughman, and E.E. Lower Leflunomide for chronic sarcoidosis Sarcoid Vasc Diffuse Lung Dis 21 2004 43 48
64. G. Haberhauer, J. Feyertag, E.M. Kittl, K. Bauer, and A. Kunky Beneficial effects of leflunomide in glucocorticoid and methotrexate-resistant Takayasu's arteritis Clin Exp Rheumatol 19 2001 477 478
65. A.G. Affleck, and H. Williams Is leflunomide effective in the treatment of psoriasis in a patient who is unable to benefit from standard first- and second-line therapies and needs an affordable treatment option? Arch Dermatol 144 2008 1642 1643